Anastrozole: what GPs need to know about its relicensing

iStock.com/sturti

By Ellie Philpotts

Breast cancer drug anastrozole has been licensed as a preventative option, rather than solely a treatment. With potentially tens of thousands of women nationwide preparing to ask their GP about their eligibility, here we answer GPs’ key questions.

Existing breast cancer drug anastrozole has been relicensed in a bid to prevent potentially thousands of cases of the disease.¹